GlobeNewswire

Dr. Timothy Noel TUe has become the new EIC of the Journal of Flow Chemistry

Share

ZURICH, Switzerland, June 07, 2019 (GLOBE NEWSWIRE) -- The Flow Chemistry Society has named Dr. Timothy Noel from Eindhoven University of Technology as the new Editor in Chief of Journal of Flow Chemistry. He succeeds Dr. Oliver Kappe (University of Graz) who held the position of Editor in Chief for 8 years.  The primary objective of the Journal of Flow Chemistry is to stimulate the development and advancement of flow chemistry for the benefit and progress of the chemistry community. The Journal provides a high-level scientific forum for rapid publication of the latest results of flow chemistry and serves as the most important information on scientific events, technology developments, products, etc. for the fast growing flow chemistry community.

Along with the installment of Dr. Timothy Noel as Editor in Chief, three new Associate Editors will join the team. This includes Dr. Jean-Christophe Monbaliu (University of Liege), Dr. Norbert Kockmann (TU Dortmund) and Dr. Shawn Collins (University of Montreal).

Statement of Timothy Noel: “It is a true honor to become the new Editor in Chief. For me, Journal of Flow Chemistry has always been about connecting the different Flow Chemistry researchers in the world and to showcase the best research this exciting field has to offer. We will continue to do that with a new set of associate editors and we will launch some brand new ideas to increase further the impact of the journal.”

Statement of C. Oliver Kappe, as the former EiC: “The past 8 years have been an exciting time for me starting the Journal of Flow Chemistry in 2010, at a time when the topic was not as popular as it is today. Being an Editor one gets in contact with many scientists in the field: authors, referees, board members, publishers, etc. I do wish the new Editorial Team all the best for the future, I am sure it will be a great success!”

Statement of Ferenc Darvas as the President of the Flow Chemistry Society: “The Journal of Flow Chemistry is the first and most important periodical of the field of flow chemistry and emerging area which was listed as the 4th most important field in IUPAC’s compilation on Ten Chemical Innovations That Will Change Our World1 (https://iupac.org/iupac-announces-the-top-ten-emerging-technologies-in-chemistry/)
The Flow Chemistry Society together with its members is enthusiastic to continue its support of the Journal.”

Statement of Akadémiai Kiadó: “The Journal of Flow Chemistry has been a success story in the Journal portfolio of our publishing house. Launching a journal in a small field is always a risky venture, but after only two years of its existence it was accepted for inclusion to the Science Citation Index and since then it has been highly read and cited, as proven by its impact factor. With Springer as co-publisher the journal now reaches an even wider audience, and the new Editor-in-Chief together with the new Associate Editors and the renewed editorial boards have our full confidence and support.”

“In recent years the field of flow chemistry has rapidly developed and so has the Journal. Being part of the success story of the 'Journal of Flow Chemistry' as co-publisher of Akadémiai Kiadó for two years now, we look forward to working with the new editorial team to continue the success of this Journal”, explained Christiane Brox, associate editor at Springer.

Contact:
szilvia.gilmore@flowchemistrysociety.com

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Notice of Extra General Meeting in Acarix AB15.7.2020 13:00:00 CESTPress release

Notice of Extra General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be held on Tuesday 11 August 2020, at 10.00 at Baker & McKenzie Advokatbyrå's premises at Vasagatan 7 in Stockholm.. Information with respect to the coronavirus Due to the development of the coronavirus the goal is that the extra general meeting shall be swift and effective to minimize spread of disease. Shareholders should carefully consider the possibility to vote in advance, please see below, as well as the possibility of participating by way of proxy. Shareholders who display symptoms of infection (dry cough, fever, respiratory distress, sore throat, headache, muscle and joint ache), have been in contact with people displaying symptoms, have visited a risk area, or belong to a risk group, are in particular encouraged to utilize such possibility. The board of directors of the Company has resolved on the following measu

Kallelse till extra bolagsstämma i Acarix AB15.7.2020 13:00:00 CESTPressemelding

Kallelse till extra bolagsstämma i Acarix AB Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma tisdagen den 11 augusti 2020 kl. 10.00 i Baker & McKenzie Advokatbyrås lokaler på Vasagatan 7 i Stockholm. Information med anledning av coronaviruset På grund av utvecklingen av coronaviruset är målsättningen att extra bolagsstämman ska bli kort och effektiv med minsta risk för smittspridning. Aktieägare bör noga överväga att använda sig av möjligheten att förhandsrösta, se nedan, samt möjligheten att delta genom ombud. Aktieägare som uppvisar symptom på smitta (torrhosta, feber, andningsbesvär, halsont, huvudvärk, muskel- och ledvärk), har varit i kontakt med personer som uppvisar symptom, har vistats i ett riskområde eller tillhör en riskgrupp, uppmanas särskilt att nyttja sig av sådan möjlighet. Bolagets styrelse har beslutat om följande åtgärder för att minimera risken för spridning av coronaviruset vid extra bolagsstämman: Möjligheten att för

AIR Collaborates with Precisely to Offer Clients Premium International Geocoding in Touchstone 202015.7.2020 12:13:10 CESTPress release

Boston, July 15, 2020 (GLOBE NEWSWIRE) -- Catastrophe modeling firm AIR Worldwide today announced that as part of its Touchstone® 2020 software release, clients now have the ability to access a premium international address-level geocoding feature from Precisely, the global leader in data integrity, to enhance the quality of their exposure data. AIR Worldwide is a Verisk (Nasdaq:VRSK) business. “Using high quality exposure data, such as any information about the property, its replacement value, and its physical characteristics including the location of that property, has a significant impact on the loss results generated by a catastrophe model,” said Gayatri Natarajan, vice president of product, AIR Worldwide. “Having the right latitude and longitude coordinates for a property can have an enormous bearing upon the accuracy of risk estimation and the impact that extreme events might have on that property. Through our collaboration with Precisely, Touchstone 2020 will help support client

Medtronic to Acquire Medicrea15.7.2020 08:30:10 CESTPress release

Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery DUBLIN and LYON, France, July 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea; OTCQX Best Market – MRNTF), a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants, today announced that they have entered into a tender offer agreement for the acquisition of all outstanding shares of Medicrea. The friendly voluntary all-cash tender offer will be at a price of €7.00 per Medicrea share (the “Tender Offer”). The Boards of Directors of both companies have unanimously approved the transaction. This acquisition would strengthen Medtronic’s position as a global innovator in enabling technologies and solutions for spine sur

Program for the publication of Yara International ASA second quarter results 202015.7.2020 08:00:00 CESTPress release

The Yara International ASA second quarter 2020 report and presentation will be published on Friday 17 July 2020at08:00 CEST. An on-line presentation and Q&A session will be held at 12:00 CEST, hosted by Yara President and CEO Svein Tore Holsether, CFO Lars Røsæg, EVP Global Plants & Operational Excellence Pål Hestad and EVP Farming Solutions Terje Knutsen. The presentation will be held in English. The report, presentation and webcast will be available at the above mentioned times at: yara.com/investor-relations/latest-quarterly-report/ Yours faithfully for Yara International ASA Thor Giæver Head of Investor Relations About Yara Yara grows knowledge to responsibly feed the world and protect the planet. Supporting our vision of a world without hunger, we pursue a strategy of sustainable value growth, promoting climate-friendly and high-yielding crop nutrition solutions for the world’s farming community and food industry. Yara’s ambition is to be the Crop Nutrition Company for the Future.

Program for offentliggjøring av Yara International ASA 2. kvartalsrapport 202015.7.2020 08:00:00 CESTPressemelding

Yara International ASAs resultatrapport og presentasjon for 2. kvartal 2020 offentliggjøres fredag 17. juli 2020kl. 08.00. Det vil holdes en nettbasert presentasjon og Q&A kl. 12.00. Resultatene vil presenteres av konsernsjef Svein Tore Holsether, finansdirektør Lars Røsæg, konserndirektør for Global plants & Operational Excellence Pål Hestad og konserndirektør for Farming Solutions Terje Knutsen. Presentasjonen vil bli holdt på engelsk. Resultatrapport, presentasjon og webcast vil være tilgjengelige til ovennevnte tider på: yara.com/investor-relations/latest-quarterly-report/ Med hilsen for Yara International ASA Thor Giæver Investorkontakt Om Yara Yara bringer kunnskap om hvordan verdens befolkning kan mettes og kloden beskyttes. Bak vår visjon om en verden uten sult ligger en strategi som fremmer klimavennlige og ressurseffektive løsninger for landbruk og matvareindustri over hele verden. Vår ambisjon er å være fremtidens leverandør av plantenæring. Vi har forpliktet oss til å skape